TITLE:
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation

CONDITION:
Hepatitis B

INTERVENTION:
Entecavir (ETV)

SUMMARY:

      This is a phase IIIb comparative study of entecavir 1.0 mg once daily (QD) vs. adefovir 10
      mg QD in patients who have chronic hepatitis B infection and hepatic decompensation. The
      patients are treated for 96 weeks after the last subject is randomized.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 16 Years to N/A
Criteria:

        Inclusion

          -  Child-Pugh (CP) score >= 7

          -  Hepatitis B virus (HBV) viremia

        Exclusion

          -  Alanine aminotransferase (ALT) > 15 x upper limit of normal (ULN)

          -  Human immunodeficiency virus (HIV)/hepatitis C virus (HCV)/hepatitis D virus (HDV)
             coinfection
      
